Inventor · disambiguated record
William Rees
Also filed as: REES WILLIAM · REES WILLIAM A
3 granted patents·12 pending applications·7 citations·filing 2012–2024
61Inventor score
Top patents by PatentIndex Score
15 records- 0181US11016099B2Prediction of clinical response to IL23-antagonists using IL23 pathway biomarkersAMGEN INC·Filed 2016·Granted May 25, 2021·3 cites·22 claims
- 0277US11220541B2CCL20 as a predictor of clinical response to IL23-antagonistsAMGEN INC·Filed 2016·Granted Jan 11, 2022·1 cites·32 claims
- 0372US9914779B2Administration of alpha4beta7 hetero-dimer-specific antibodyAMGEN INC·Filed 2012·Granted Mar 13, 2018·3 cites·23 claims
- 0471US2025019408A1Cd40l antagonist and uses thereofVIELA BIO INC·Filed 2024·Application pending·0 cites
- 0563US2022144935A1Ccl20 as a predictor of clinical response to il23-antagonistsAMGEN INC·Filed 2021·Application pending·0 cites
- 0661US2024383991A1Cd40l-specific tn3-derived scaffolds for the treatment and prevention of sjögren's syndromeVIELA BIO INC·Filed 2024·Application pending·0 cites
- 0759US2023406928A1Methods of treating neuromyelitis optica spectrum disorderVIELA BIO INC·Filed 2022·Application pending·0 cites
- 0858US2021340200A1Cd40l antagonist and uses thereofVIELA BIO INC·Filed 2019·Application pending·0 cites
- 0957US2024368294A1Cd40l-specific tn3-derived scaffolds for use in the treatment and prevention of rheumatoid arthritisVIELA BIO INC·Filed 2024·Application pending·0 cites
- 1056US2023287114A1Use of an anti-cd19 antibody to treat autoimmune diseaseVIELA BIO INC·Filed 2023·Application pending·0 cites
- 1153US2022373539A1Prediction of clinical response to il23-antagonists using il23 pathway biomarkersAMGEN INC·Filed 2021·Application pending·0 cites
- 1253US2024084024A1Cd40l antagonist and uses thereof in the treatment of lupus nephritisVIELA BIO INC·Filed 2023·Application pending·0 cites
- 1351US2023151093A1Methods of treating immune mediated pulmonary injuryVIELA BIO INC·Filed 2022·Application pending·0 cites
- 1451US2022403020A1Methods of treatment using ilt7 binding proteinsVIELA BIO INC·Filed 2022·Application pending·0 cites
- 1549US2024287176A1Methods of treatment of autoimmune disorders using ilt7 binding proteinsVIELA BIO INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William Rees files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →